DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Korzenik J, Lashner B. et al.
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
Gastroenterology 2010;
138: 1286-1296, 1296 e1–3
We do not assume any responsibility for the contents of the web pages of other providers.